Pharmaids Pharmaceuticals Ltd

NSE: BSE: 524572

₹32.01

(-3.58%)

Mon, 30 Mar 2026, 07:01 am

MTF 5xInvest in Pharmaids Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap1.13B

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Pharmaids Pharmaceuticals EV/EBITDA Ratio

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Price to earnings ratio	0	0	0	0	0	0	26.36	19.33	0	0	0	11.88	0	0	138.46	123.54	88.85	0	0	0
Price to book ratio	0	0.55	0.77	0.36	0.44	1	0.48	0.47	0.47	0.61	1.46	0.94	0.94	0.58	0.55	1.37	1.50	2.10	2.55	4.09
Price to sales ratio	14.46	3.15	4.16	2.19	1.97	2.71	0.81	0.78	0.60	0.58	1.09	1.08	2.06	8.67	0	1.35	3.27	0	7.82	12.45
Price to cash flow ratio	0	0	20	21.39	17.70	17.63	3.98	5.87	10.90	4.78	0	4.35	0	0	0	28.44	0	0	0	0
Enterprise value	0	24.97M	28.98M	18.05M	18.86M	28.74M	15.14M	13.47M	10.58M	11.14M	21.41M	6.85M	6.87M	47.48M	46.18M	113.28M	124.92M	120.67M	1.2B	2.75B
Enterprise value to EBITDA ratio	0	0	0	0	0	0	11.20	17.80	0	0	0	0	0	0	0	95.98	91.12	0	0	0
Debt to equity ratio	0	0.42	0.44	0.44	0.46	0.48	0.27	0.24	0.20	0.18	0.38	0	0	0	0	0	0	0	0.12	0.66
Return on equity %	0	0	-7.64	-4.63	-5.50	-5.17	1.80	2.50	-18.51	-3.83	-27.23	8.34	-32.75	-3.80	0.73	1.11	1.71	-48.85	-16.89	-16.43

Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio

The Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Pharmaids Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Pharmaids Pharmaceuticals Ltd (NSE: , BSE: 524572) is currently trading at ₹32.01, with a market capitalization of ₹1.13B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio Current Value

The current Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio stands at 0.

The Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio remains stable, indicating consistent financial performance.

Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

2024: 0
2023: 0
2022: 0
2021: 91.12
2020: 95.98

The decline in Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.

What Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Pharmaids Pharmaceuticals Ltd.

Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Pharmaids Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800